Medicare billing address
CMS Medicare provider billing file
33 W Chester PikeRidley Park, PA 19078
CMS public data · NPI 1205869948
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Rashmi Sanjay, M.D.
Specialty
Credential
M.D.
NPI
1205869948
Primary source state
PA
Data retrieval date
July 27, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Rashmi Sanjay, M.D. from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
33 W Chester PikeCMS Doctors & Clinicians file
33 W Chester PikeIn the 2024 CMS provider billing file, this NPI had 673 Medicare beneficiaries and 120,773 total services. The average beneficiary age was 74, and the average HCC risk score was 1.6.
Total Medicare allowed amount
$2,675,045.83
Total Medicare payment amount
$2,122,836.75
Medicare beneficiaries
673
Total services
120,773
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
73%
CMS beneficiary-panel share
Diabetes
29%
CMS beneficiary-panel share
Ischemic heart disease
29%
CMS beneficiary-panel share
Anxiety
28%
CMS beneficiary-panel share
Chronic kidney disease
24%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, fosaprepitant, 1 mg | 11,250 | $0.14 |
| Injection, pembrolizumab, 1 mg | 8,600 | $56.09 |
| Injection, denosumab, 1 mg | 5,340 | $25.57 |
| Injection, eflapegrastim-xnst, 0.1 mg | 3,960 | $26.16 |
| Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 3,340 | $2.93 |
| Injection, ferric derisomaltose, 10 mg | 3,200 | $19.70 |
| Injection, dexamethasone sodium phosphate, 1 mg | 2,168 | $0.11 |
| Injection, palonosetron hcl, 25 mcg | 1,190 | $0.92 |
| Insertion of needle into vein for collection of blood sample | 920 | $8.65 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 866 | $135.80 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1205869948. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Letrozole | Letrozole | 376 | 1,063 | $10,322.98 |
| 2 | Anastrozole | Anastrozole | 176 | 470.1 | $5,560.05 |
| 3 | Exemestane | Exemestane | 63 | 135 | $8,124.22 |
| 4 | Ibrance | Palbociclib | 42 | 42 | $711,746.42 |
| 5 | Famotidine | Famotidine/Pf | 41 | 41 | $450.04 |
| 6 | Alendronate Sodium | Alendronate Sodium | 39 | 76.8 | $249.21 |
| 7 | Eliquis | Apixaban | 28 | 52 | $30,021.72 |
| 8 | Xarelto | Rivaroxaban | 27 | 35 | $19,126.56 |
| 9 | Hydroxyurea | Hydroxyurea | 21 | 61 | $687.73 |
| 10 | Ibandronate Sodium | Ibandronate Sodium | 16 | 47.8 | $1,195.44 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Graduation year
1997
Group/practice field
Alliance Cancer Specialists P.C.
Telehealth reported
Not reported
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.